AGER and autoimmune hepatitis: Taken together, our findings indicate that serum EN-RAGE, sRAGE or EN-RAGE/sRAGE exhibited potentials as novel biomarkers for the diagnosis and prognosis evaluation in AIH patients, opening a very attractive field of research on these molecules in the pathology of AIH and identification of therapeutic targets.